The European Qualifications (Health and Social Care Professions) (Amendment etc.) (EU Exit) Regulations 2019

PART 1 U.K. Amendments to legislation

Interpretation U.K.

1.  In this Schedule—

(a) “the 1968 Act” means the Medicines Act 1968 M1 ;

(b) “the 2010 Order” means the Pharmacy Order 2010 M2 .

Commencement Information

I1 Sch. 2 para. 1 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M1 1968 c. 67.

M2 S.I. 2010/231.

Medicines Act 1968 U.K.

2.  The 1968 Act is amended as follows.

Commencement Information

I2 Sch. 2 para. 2 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

3.  In section 67E (interpretation of provisions about defences) M3 , in the definition of “registrant”— U.K.

(a) in paragraph (a), for “2, 4 or 5” substitute “ or 2 ”;

(b) in paragraph (b), omit the words from “or the register” to “European State”.

Commencement Information

I3 Sch. 2 para. 3 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M3 Section 67E was inserted by S.I. 2018/181.

4.  In section 69 (general provisions about pharmacies) M4 , omit subsection (1ZA). U.K.

Commencement Information

I4 Sch. 2 para. 4 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M4 Subsection (1ZA) was inserted by S.I. 2007/3101. Relevant amending instrument is S.I. 2010/231.

5.  In section 71 (business carried on by body corporate) M5 , omit subsection (7). U.K.

Commencement Information

I5 Sch. 2 para. 5 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M5 Subsection (7) was substituted by S.I. 2010/231.

6.  In section 78 (restrictions on use of titles etc.) M6 — U.K.

(a) in subsection (5), omit the words from “or in the” to “European State”;

(b) in subsection (5A), omit “or 4”.

Commencement Information

I6 Sch. 2 para. 6 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M6 Subsections (5) and (5A) were substituted by S.I. 2010/231.

Pharmacy Order 2010 U.K.

7.  The 2010 Order is amended as follows.

Commencement Information

I7 Sch. 2 para. 7 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

8.  In article 3 (interpretation) M7 [F1 , in sub-paragraph (1)]— U.K.

(a) for the definition of “the Directive” substitute—

““the Directive” means Directive 2005/36/EC of the European Parliament and of the Council of 7th September 2005 on the recognition of professional qualifications (OJ No L255, 30.09.2005, p 22), and any reference in this Order to the Directive or to any provision of the Directive is a reference to the Directive, or to that provision, as it had effect immediately before [F2 IP completion day];”;

(b) omit the definitions of “competent authority”, “Directive 2002/58/EC”, “European mutual recognition area”, “European professional card”, “exempt person”, “General Systems Regulations”, “IMI”, “IMI file” and “third country”;

(c) in the definition of “registered pharmacist”, omit “or 4”;

(d) in the definition of “registered pharmacy technician”, omit “or 5”.

Textual Amendments

F1 Words in Sch. 2 para. 8 inserted (31.12.2020 immediately before IP completion day) by The European Qualifications (Health and Social Care Professions) (EFTA States) (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1394), regs. 1(2), 10(2)(a)

F2 Words in Sch. 2 para. 8(a) substituted (31.12.2020 immediately before IP completion day) by The European Qualifications (Health and Social Care Professions) (EFTA States) (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1394), regs. 1(2), 10(2)(b)

Commencement Information

I8 Sch. 2 para. 8 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M7 Relevant amending instruments are S.I. 2011/1043, 2016/1030.

9.  In article 19 (establishment, maintenance of, and access, to the Register), in paragraph (2)— U.K.

(a) in the words before paragraph (a), for “five” substitute “ three ”;

(b) in paragraphs (a) and (b), omit “other than visiting practitioners”;

(c) at the end of paragraph (b), insert “ and ”;

(d) omit sub-paragraph (d) (including the final “and”);

(e) omit sub-paragraph (e).

Commencement Information

I9 Sch. 2 para. 9 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

10.  In article 20 (entitlement to entry in Parts 1 or 2 of the Register), for paragraph (4), substitute— U.K.

“(4) The Registrar must treat a person who—

(a) applies to be entered in Part 1 of the Register as a pharmacist,

(b) qualified as a pharmacist in a relevant European State,

(c) was, on [F3 IP completion day], in the register of pharmaceutical chemists for Northern Ireland, or was entered in that register on or after [F3 IP completion day] further to an application made before [F3 IP completion day], and

(d) has remained in that register since [F3 IP completion day] or, as the case may be, since that entry (disregarding any period in which the person was not in the register as a result of a decision that was later overturned in an appeal or other legal proceeding),

as meeting the requirements of paragraph (1)(a)(i).”.

Textual Amendments

F3 Words in Sch. 2 para. 10 substituted (31.12.2020 immediately before IP completion day) by The European Qualifications (Health and Social Care Professions) (EFTA States) (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1394), regs. 1(2), 10(3)

Commencement Information

I10 Sch. 2 para. 10 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

11.—(1) Article 21 (pre-entry requirements in respect of qualifications and additional education, training or experience: pharmacists) M8 is amended as follows. U.K.

(2) In paragraph (1)—

(a) in sub-paragraph (a), omit the words from “(and” to the end;

(b) omit sub-paragraph (b);

(c) omit sub-paragraph (c) (but not the final “or”);

(d) in sub-paragraph (d)—

(i) in the words before paragraph (i), omit “subject to paragraph (2),”;

(ii) omit paragraph (ii)(aa) (including the final “or”);

(iii) in paragraph (ii)(bb), omit “whether or not P is an exempt person,”.

(3) After paragraph (1), insert—

“(1A) A relevant European qualification is to be treated as a qualification which has been approved under paragraph (1)(d)(i).

(1B) In this article “relevant European qualification” means—

(a) a qualification that falls within article 21A and has not been designated by the Council for the purposes of this sub-paragraph, or

(b) a qualification in pharmacy that does not fall within article 21A but—

(i) was granted in a relevant European State, and

(ii) attests, in the opinion of the Council, to a comparable standard of proficiency to that attested to by a qualification approved under paragraph (1)(a).

(1C) The Council—

(a) may designate a qualification for the purposes of paragraph (1B)(a) only with the approval of the Privy Council;

(b) must maintain and publish a list of the qualifications that are so designated.”.

(4) Omit paragraphs (2) to (5).

Commencement Information

I11 Sch. 2 para. 11 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M8 Relevant amending instrument is 2016/1030.

12.  After article 21, insert— U.K.

“European qualifications: pharmacists

21A.— (1) Subject to the following provisions of this article, a qualification falls within this article if it was awarded in a relevant European State and is listed in Annex V, point 5.6.2 of the Directive.

(2) A qualification falls within this article only if it is accompanied, where applicable, by the certificate listed in relation to the qualification in the column entitled “Certificate accompanying the diploma” in Annex V, point 5.6.2 of the Directive.

(3) A qualification does not fall within this article if it was awarded before the reference date, or is evidence of training begun before that date.

(4) In paragraph (3) “reference date” means the date listed in relation to the State in which the qualification was awarded in the column entitled “Reference date” in Annex V, point 5.6.2 of the Directive.”.

Commencement Information

I12 Sch. 2 para. 12 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

13.—(1) Article 22 (pre-entry requirements in respect of qualifications and additional education, training or experience: pharmacy technicians) is amended as follows. U.K.

(2) In paragraph (1)—

(a) in sub-paragraph (a), at the end insert “ or ”;

(b) omit sub-paragraph (b) (including the final “or”);

(c) in sub-paragraph (c)—

(i) in paragraph (i), omit the final “or”;

(ii) after paragraph (i), insert—

“(ia) holds a qualification which was granted in a relevant European State and, despite its not having been approved under paragraph (i), attests, in the opinion of the Council, to a comparable standard of proficiency to that attested to by a qualification approved under paragraph (1)(a), or”;

(iii) omit paragraph (ii)(aa);

(iv) in paragraph (ii)(bb) omit “whether or not T is an exempt person,”.

(3) Omit paragraphs (2) and (3).

Commencement Information

I13 Sch. 2 para. 13 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

14.—(1) Article 23 (form, manner and content of applications for entry or for renewal of an entry in the register: pharmacists and pharmacy technicians) M9 is amended as follows. U.K.

(2) In paragraph (1)(c)—

(a) in paragraph (iii)—

(i) omit “who is not an exempt person”;

(ii) at the end insert “ and ”;

(b) omit paragraph (iv);

(c) omit paragraph (vi) (including the final “and”).

(3) Omit paragraphs (4) to (11).

Commencement Information

I14 Sch. 2 para. 14 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M9 Relevant amending instrument is S.I. 2016/1030.

15.  In article 23A (supplementary provisions as to necessary knowledge of English) M10 , omit paragraphs (5) and (7). U.K.

Commencement Information

I15 Sch. 2 para. 15 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M10 Article 23A was inserted by S.I. 2015/806.

16.—(1) Article 24 (notification by the Registrar: entry and renewal) M11 is amended as follows. U.K.

(2) Omit paragraphs (2A) and (2B).

(3) In paragraph (3), for “specified period” substitute “ period of three months beginning with the relevant date ”.

(4) In paragraph (4)—

(a) omit sub-paragraph (a) (including the final “or”);

(b) in the words after sub-paragraph (b)—

(i) omit the words from “a decision”, where it first occurs, to “or”;

(ii) omit “(as the case may be)”;

(iii) for “specified period” substitute “ period of three months beginning with the relevant date ”.

(5) Omit paragraph (5).

(6) In paragraph (5A), for “any period of time for the purposes of paragraph (5)” substitute “ the period of three months for the purposes of paragraph (3) or (4) ”.

Commencement Information

I16 Sch. 2 para. 16 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M11 Paragraphs (2A), (2B) and (5A) were inserted, and paragraphs (4) and (5) were amended, by S.I. 2015/806.

17.  In article 29 (corrections to the Register), in paragraph (3)(a), omit “or in Part 4 or 5 of the Register”. U.K.

Commencement Information

I17 Sch. 2 para. 17 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

18.  In article 32 (indemnity arrangements) M12 , omit paragraph (11). U.K.

Commencement Information

I18 Sch. 2 para. 18 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M12 Article 32 was substituted by S.I. 2014/1887.

19.  Omit article 33 (visiting pharmacists and pharmacy technicians from relevant European States). U.K.

Commencement Information

I19 Sch. 2 para. 19 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

20.  Omit article 33A (European professional card) M13 . U.K.

Commencement Information

I20 Sch. 2 para. 20 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M13 Article 33A was inserted by S.I. 2016/1030. Relevant amendments made by paragraph 354 of Schedule 19 to the Data Protection Act 2018.

21.  In article 36 (fees in connection with entry)— U.K.

(a) in paragraph (1), for “Subject to paragraph (3), the” substitute “ The ”;

(b) omit paragraph (3).

Commencement Information

I21 Sch. 2 para. 21 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

22.  In article 37 (restoration to the Register), in paragraph (5), for “, 2, 4 or 5” substitute “ or 2 ”. U.K.

Commencement Information

I22 Sch. 2 para. 22 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

23.—(1) Article 38 (offences relating to the Register) is amended as follows. U.K.

(2) In paragraph (2)—

(a) in sub-paragraph (a), omit “or 4”;

(b) in sub-paragraph (b), omit “or 5”.

(3) In paragraph (4)—

(a) in sub-paragraph (a), omit “or 4”;

(b) in sub-paragraph (b), omit “or 5”.

Commencement Information

I23 Sch. 2 para. 23 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

24.—(1) Article 39 (appealable decisions) M14 is amended as follows. U.K.

(2) In paragraph (1)—

(a) omit sub-paragraphs (a), (c), (cb) and (e);

(b) in sub-paragraphs (i) and (l), for “, 2, 4 or 5” substitute “ or 2 ”;

(c) omit sub-paragraphs (t) and (u).

(3) Omit paragraph (1A).

Commencement Information

I24 Sch. 2 para. 24 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M14 Paragraph (1)(cb) was inserted by S.I. 2015/806. Paragraph (1)(t) and (u) and (1A) were inserted by S.I. 2016/1030.

25.  In article 40 (appeals to the Appeals Committee) M15 — U.K.

(a) omit paragraph (1A);

(b) in paragraph (2), omit sub-paragraph (b) (together with the “or” before it);

(c) in paragraph (7)—

(i) in sub-paragraph (b), omit the words from “or, in” to the end;

(ii) omit sub-paragraph (ca) (but not the final “or”).

Commencement Information

I25 Sch. 2 para. 25 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M15 Paragraphs (1A) and (7)(ca) were inserted by, and paragraph (7)(b) was amended by, S.I. 2016/1030.

26.  In article 41 (appeals from the Appeals Committee) M16 , in paragraph (4)— U.K.

(a) in sub-paragraph (b), omit the words from “or, in” to the end;

(b) omit sub-paragraph (ca) (but not the final “or”).

Commencement Information

I26 Sch. 2 para. 26 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M16 Paragraph (4)(ca) was inserted by, and paragraph (4)(b) was amended by, S.I. 2016/1030.

27.  In article 42 (education, training and acquisition of experience) M17 , in paragraph (1)(a), omit from “except” to “22(1)(b),”. U.K.

Commencement Information

I27 Sch. 2 para. 27 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M17 Relevant amending instrument is S.I. 2016/1030.

28.  Omit article 42A (professional traineeships carried out in other relevant European States, etc) M18 . U.K.

Commencement Information

I28 Sch. 2 para. 28 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M18 Article 42A was inserted by S.I.2016/1030.

29.  In article 43 (continuing professional development)— U.K.

(a) omit paragraph (5)(c);

(b) omit paragraph (8)(b);

(c) omit paragraph (9).

Commencement Information

I29 Sch. 2 para. 29 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

30.  In article 66 (rules), omit paragraph (2). U.K.

Commencement Information

I30 Sch. 2 para. 30 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

31.  Omit article 67 (The Directive: designation of competent authority etc) M19 . U.K.

Commencement Information

I31 Sch. 2 para. 31 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M19 Relevant amendments made by paragraph 357 of Schedule 19 to the Data Protection Act 2018, S.I. 2016/1030.

32.  Omit article 71 (review) M20 . U.K.

Commencement Information

I32 Sch. 2 para. 32 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M20 Article 71 was inserted by S.I. 2016/1030.

33.  Omit Schedule 2 (visiting pharmacists and pharmacy technicians from relevant European States) M21 . U.K.

Commencement Information

I33 Sch. 2 para. 33 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M21 Relevant amending instrument is S.I. 2016/1030.

34.  Omit Schedule 2A (European professional card) M22 . U.K.

Commencement Information

I34 Sch. 2 para. 34 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M22 Schedule 2A was inserted by S.I. 2016/1030. Relevant amendments made by paragraph 358 of Schedule 19 to the Data Protection Act 2018.

35.  Omit Schedule 3 (The Directive: designation of competent authority etc) M23 . U.K.

Commencement Information

I35 Sch. 2 para. 35 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M23 Relevant amendments made by paragraph 359 of Schedule 19 to the Data Protection Act 2018, S.I. 2015/806, 2016/1030.

Medicines for Human Use (Clinical Trials) Regulations 2004 U.K.

36.  In the Medicines for Human Use (Clinical Trials) Regulations 2004 M24 , in regulation 2(1) (interpretation), in the definition of “pharmacist”—

(a) in paragraph (a), omit “or 4”;

(b) in paragraph (b), omit the words from “, or the” to “European State,”.

Commencement Information

I36 Sch. 2 para. 36 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M24 S.I. 2004/1031. Paragraph (a) was substituted by S.I. 2010/231, and paragraph (b) was amended by, S.R. 2008 No.192.

Approved European Pharmacy Qualifications Order of Council 2007 U.K.

37.  The Approved European Pharmacy Qualifications Order of Council 2007 M25 is revoked.

Commencement Information

I37 Sch. 2 para. 37 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M25 S.I. 2007/564.

National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009 U.K.

38.  In the National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009 M26 , in regulation 2 (interpretation), in paragraph (1), in the definition of “pharmacist”, omit “or 4”.

Commencement Information

I38 Sch. 2 para. 38 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M26 S.S.I. 2009/183. Relevant amending instrument is S.I. 2010/231.

General Pharmaceutical Council (Registration) Rules 2010 U.K.

39.—(1) The General Pharmaceutical Council (Registration) Rules 2010 M27 are amended as follows.

(2) In rule 10 (entry in the Register)—

(a) in paragraph (3)—

(i) omit sub-paragraphs (e), (f), (h) and (i);

(ii) in sub-paragraph (j)—

(aa) omit paragraph (i) (including the final “or”);

(bb) in paragraph (ii), omit from “in”, where it first occurs, to “way),”;

(iii) in sub-paragraph (k)—

(aa) omit paragraph (i) (including the final “and”);

(bb) in paragraph (ii), omit “whether or not the applicant is an exempt person,”;

(b) omit paragraph (3ZA);

(c) in paragraph (12), omit the definition of “attesting state” (including the final “and”).

(3) In the heading to Part 4, for “, 2, 4 and 5” substitute “ and 2 ”.

(4) In rule 18 (notice of intention to remove: stage 1)—

(a) in paragraph (1)(a), omit “, 4 or 5”;

(b) in paragraph (5)(a)(i), omit “, 4 or 5”.

(5) In rule 19 (subsequent action by Registrar: stage 2)—

(a) in paragraph (1), omit “, 4 or 5”;

(b) in paragraph (4)(a), omit “, 4 or 5”;

(c) in paragraph (5)(b), omit “, 4 or 5”.

(6) In rule 20 (decisions in contested cases: stage 3), in paragraph (3)(a), omit “, 4 or 5”.

Commencement Information

I39 Sch. 2 para. 39 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M27 As set out in the Schedule to the General Pharmaceutical Council (Registration Rules) Order of Council 2010 (S.I. 2010/1617). Paragraph 10(3ZA) was inserted by S.I. 2016/1030. Paragraph 10(12) was substituted by S.I. 2010/2660. Relevant amending instruments are S.I. 2012/3171, 2016/1008, 1030.

Pharmacy Order 2010 (Approved European Pharmacy Qualifications) Order 2010 U.K.

40.  The Pharmacy Order 2010 (Approved European Pharmacy Qualifications) Order 2010 M28 is revoked.

Commencement Information

I40 Sch. 2 para. 40 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M28 S.I. 2010/1620.

General Pharmaceutical Council (Continuing Professional Development and Consequential Amendments) Rules 2011 U.K.

41.—(1) The General Pharmaceutical Council (Continuing Professional Development and Consequential Amendments) Rules 2011 M29 are amended as follows.

(2) In rule 5 (steps which the Registrar may take)—

(a) in paragraph (2)(b), for “, 2, 4 or 5” substitute “ or 2 ”;

(b) omit paragraph (3).

(3) In rule 6 (remedial measures), in paragraph (1)(f), omit paragraph (ii) and the “or” before it.

(4) In rule 8 (subsequent action by the Registrar: stage 2), in paragraph (1), for “, 2, 4 or 5” substitute “ or 2 ”.

(5) In rule 9 (decisions in contested cases: stage 3), in paragraph (5), for “, 2, 4 or 5” substitute “ or 2 ”.

(6) In rule 11 (suspension from the register pending appeal), in paragraph (1)(a), for “, 2, 4 or 5” substitute “ or 2 ”.

Commencement Information

I41 Sch. 2 para. 41 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M29 As set out in the Schedule to the General Pharmaceutical Council (Continuing Professional Development and Consequential Amendments) Rules Order of Council 2011 (S.I. 2011/1367).

Human Medicines Regulations 2012 U.K.

42.  In the Human Medicines Regulations 2012 M30 , in regulation 8(1) (interpretation)—

(a) in the definition of “health care professional”, in paragraph (d), omit “or 5”;

(b) in the definition of “pharmacist”—

(i) in paragraph (a), omit “or 4”;

(ii) in paragraph (b), omit the words from “or the” to “European State”.

Commencement Information

I42 Sch. 2 para. 42 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M30 S.I. 2012/1916.

National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 U.K.

43.  In the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 M31 , in regulation 2(1)—

(a) in the definition of “registered pharmacist”, omit “or 4”;

(b) in the definition of “registered pharmacy technician”, omit “or 5”.

Commencement Information

I43 Sch. 2 para. 43 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M31 S.I. 2013/349.